Eli Lilly and CompanyLLY
▲ ポジティブ規制関連度
Selected for FDA PreCheck Pilot Program, improving US drug manufacturing capabilities with earlier FDA engagement.
銘柄への影響 4
Biotech & Genomic Medicine
Eli Lilly and Company
Regeneron Pharmaceuticals IncREGN
▲ ポジティブ規制関連度
Selected for FDA PreCheck Pilot Program, providing more predictable regulatory pathway for US manufacturing.
Kyowa Kirin Co., Ltd.4151
▲ ポジティブ規制関連度
Selected for FDA PreCheck Pilot Program, offering earlier FDA engagement and predictable regulatory pathway.
Amneal Pharmaceuticals, Inc. Class A Common StockAMRX
▲ ポジティブ規制関連度
Selected for FDA PreCheck Pilot Program, offering earlier engagement and predictable regulatory pathway for US manufacturing.